Zobrazeno 1 - 6
of 6
pro vyhledávání: '"CD8+ T cell subpopulations"'
Autor:
Weiwei Deng, Yubo Ma, Zhen Su, Yufang Liu, Panpan Liang, Chen Huang, Xiao Liu, Jin Shao, Yi Zhang, Kai Zhang, Jian Chen, Ruoyu Li
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 105-118 (2021)
CD8+ T cells are crucial to establish antitumor immunity, and their high infiltration associates with favorable prognoses. However, several CD8+ T cell subpopulations in the tumor microenvironment may play different roles in prognosis, progression, a
Externí odkaz:
https://doaj.org/article/7fbf60f682f34cff817259ed3fc41aff
Autor:
Chen Huang, Jin Shao, Jian Chen, Panpan Liang, Kai Zhang, Yufang Liu, Ruoyu Li, Zhen Su, Yubo Ma, Yi Zhang, Weiwei Deng, Xiao Liu
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 105-118 (2021)
CD8+ T cells are crucial to establish antitumor immunity, and their high infiltration associates with favorable prognoses. However, several CD8+ T cell subpopulations in the tumor microenvironment may play different roles in prognosis, progression, a
Autor:
Weiwei, Deng, Yubo, Ma, Zhen, Su, Yufang, Liu, Panpan, Liang, Chen, Huang, Xiao, Liu, Jin, Shao, Yi, Zhang, Kai, Zhang, Jian, Chen, Ruoyu, Li
Publikováno v:
Molecular Therapy Oncolytics
CD8+ T cells are crucial to establish antitumor immunity, and their high infiltration associates with favorable prognoses. However, several CD8+ T cell subpopulations in the tumor microenvironment may play different roles in prognosis, progression, a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Deng W; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Ma Y; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Su Z; Department of Dermatology and Venerology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China., Liu Y; Department of Dermatology and Venerology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China., Liang P; Clinical Laboratory, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China., Huang C; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Liu X; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Shao J; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Zhang Y; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Zhang K; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China., Chen J; Department of Dermatology and Venerology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China., Li R; Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.; Research Center for Medical Mycology, Peking University, Beijing 100034, China.; Beijing Key Laboratory of Molecular Diagnosis of Dermatoses, Peking University First Hospital, Beijing, China.; National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
Publikováno v:
Molecular therapy oncolytics [Mol Ther Oncolytics] 2020 Dec 15; Vol. 20, pp. 105-118. Date of Electronic Publication: 2020 Dec 15 (Print Publication: 2021).